Journal Information
Vol. 35. Issue 9.
Pages 422-427 (October 1999)
Share
Share
Download PDF
More article options
Vol. 35. Issue 9.
Pages 422-427 (October 1999)
Full text access
Validación de la versión española del test de somnolencia Epworth en pacientes con síndrome de apnea de sueño
Validation of the Spanish versión of the Epworth Sieepiness Scale in patients with sieep apnea syndrome
Visits
12553
E. Chiner*, J.M. Arriero, J. Signes-Costa, J. Marco, I. Fuentes
Sección de Neumología. Hospital Universitari Sant Joan d’Alacant
This item has received
Article information
Abstract
Bibliography
Download PDF
Statistics

Se obtuvo una versión española del test de somnolencia Epworth (ESS) mediante el método de traducción, retrotraducción, discusión formal y reunión de investigadores con un grupo de pacientes con síndrome de apnea de sueño (SAS). El cuestionario definitivo fue testado en 345 pacientes, 275 afectados de SAS con diferentes grados de severidad y 70 sin SAS. Existieron diferencias significativas entre ambos grupos en la edad (53 ±11 frente a 47±13 años, p<0,001) y el índice de masa corporal (IMC) (32±5 frente a 29,5±5, p<0,001). Los pacientes con SAS presentaron puntuaciones significativamente más altas (14±5) respecto a los pacientes sin SAS (10±5) (p<0,001). La reproducibilidad se testó en 146 pacientes (113 SAS y 33 no SAS), no observando diferencias significativas en los pacientes con SAS (14,9±5 frente a 14,2±5, p=NS) aunque sí en los 33 pacientes sin SAS (12±5 frente a 10±5, p<0,01). Se obtuvieron correlaciones significativas tanto en la puntuación total como en cada ítem en ambos grupos. Asimismo, cada ítem se correlacionó con la puntuación total en pacientes con SAS. La sensibilidad a los cambios postratamiento fue evaluada en 77 pacientes con SAS. La puntuación inicial de 16±4 disminuyó a 4±3 tras tratamiento con presión positiva continua (CPAP). Se observó un ESS>10 en el 85% de pacientes con SAS, en el 78% del grado leve, en el 85% del moderado y en el 92% del severo. Se observaron diferencias significativas entre grupos al aplicar el análisis de la variancia (p<0,001), y fueron asimismo significativas las comparaciones múltiples, con grados más altos al aumentar la severidad. Los pacientes con SAS y grado de ESS1<10 presentaron un índice de apnea-hipopnea (IAH) menor (35±18 frente a 42±20, p<0,005), menor índice de desaturación (21±21 frente a 34±28, p<0,01) y mayor saturación mínima (80±10 frente a 75±12, p<0,05), sin observarse diferencias en la edad ni en el IMC. Se obtuvo una correlación significativa entre el ESS y las variables respiratorias de la polisomnografía: IAH (r=0,23, p<0,001), porcentaje de tiempo en apnea-hipopnea (r=0,18, p<0,01), índice de desaturaciones (r=0,27, p<0,01) y saturación mínima (r=0,14, p<0,05). Concluimos que la versión española del ESS es equivalente a la versión original, es reprodutible en pacientes con SAS, sensible a los cambios postratamiento y parece discriminar el grado de severidad presentando una correlación significativa con las variables obtenidas en la polisomnografía.

Palabras clave:
Síndrome de apnea de sueño
Test de somnolencia Epworth
Validación

A Spanish version of the Epworth Sleepiness Scale (ESS-Sp) was developed by translation, back-translation, formal discussion, and a meeting of researchers with a group of patients with sleep apnea syndrome (SAS). The translated questionnaire was then tested in 345 patients, 275 with SAS at various levels of severity and 70 without SAS. Significant differences existed between the two groups as to age (53 ±11 years versus 47±13, p<0.001) and BMI (32±5 versus 29.5±5, p<0.001). Patients with SAS had significantly higher scores (14±5) than did those without SAS (10±5) (p<0.001). Reproducibility was tested in 146 patients (113 SAS and 33 non-SAS), with no significant differences found among patients with SAS (14.9±5 versus 14.2±5, p=n.s.); significant differences in BMI were found, however, among the 33 non-SAS patients (12±5 versus 10±5, p<0.01). Total scores and individual item scores were related in both groups. Likewise, each item was related to total score in patients with SAS. Sensitivity to post-treatment changes was assessed in 77 SAS patients, with initial scores of 16±4 seen to decrease to 4±3 after continuous positive airway pressure. ESS-Sp scores over 10 were recorded for 85% of patients with SAS: 78% of those with mild SAS, 85% of those with modérate disease and 92% of those whose SAS was severe. Significant inter-group differences were found upon applying a test of variance (p<0.001). Differences continued to be detected when multiple correlations were looked for, with differences increasing with severity. SAS patients with ESS-Sp level one scores (<10) had lower apnea-hypopnea indices (AHI) (35±18 versus 42±20, p<0.05), lower desaturation levels (21±21 versus 34±28, p<0.01) and higher minimum saturation (80±10 versus 75±12, p<0.05), with no differences in age or BMI. A significant correlation was found between ESS-Sp score and respiratory variables recorded during polysomnography: AHI, r=0.23 (p<0.001); percent time in apnea-hypopnea, r=0.18 (p<0.01); desaturation index, r=0.27 (p<0.01) and mínimum saturation (r=0.14, p<0.05). We conclude that the Spanish version of the ESS is equivalent to the original, is reproducible in patients with SAS, sensitive to post-treatment changes and seems to discriminate level of severity, showing correlation with polysomnograph variables.

Key words:
Sleep apnea syndrome
Epworth Sleepiness Scale
Validation
Full text is only aviable in PDF
Bibliografía
[1.]
M.A. Carskadon, W.C. Dement.
The multiple sleep latency test: what does it measure?.
Sleep, 5 (1985), pp. S67-S72
[2.]
M. Mitler, K.S. Gujavarty, C.P. Browman.
Maintenance of wakefulness test: a polysomnographic technique for evaluating treatment in patients with excessive somnolence.
Electroencephalogr Clin Neurophysiol, 153 (1982), pp. 658-661
[3.]
T. Rohers, F. Zorick, R. Wittig, W. Conway, T. Roth.
Predictors of objective level of daytime sleepiness in patients with sleep related breathing disorders.
Chest, 95 (1989), pp. 1.202-1.206
[4.]
M.W. Johns.
A new method for measuring daytime sleepiness: the Epworth Sleepiness Scale.
Sleep, 14 (1991), pp. 540-545
[5.]
M.W. Johns, Daytime sleepiness, snoring, obstructive sleep apnea.
The Epworth Sleepiness Scale.
Chest, 103 (1993), pp. 30-36
[6.]
M.W. Johns.
Reliability and factor analysis of the Epworth Sleepiness Scale.
Sleep, 15 (1992), pp. 376-381
[7.]
N.K. Aaronson, C. Acquadro, J. Alonso, G. Apolone, D. Bucquet, M. Bullinger, et al.
International quality of life assessment (IQOLA) project.
Qual Life Res, 1 (1992), pp. 349-351
[8.]
M. Perpiñá, A. Belloch, L.M. Pascual, A. De Diego, L. Compte.
Calidad de vida en el asma: validación del cuestionario AQLQ para su utilización en población española.
Arch Bronconeumol, 21 (1995), pp. 211-218
[9.]
C. Sanjuas, J. Alonso, J. Sanchís, P. Casan, J.M. Broquetas, P.J. Ferrie, et al.
Cuestionario de calidad de vida en pacientes con asma: la versión española del Asthma Quality of Life Questionnaire.
Arch Bronconeumol, 31 (1995), pp. 219-226
[10.]
G.A. Gould, K.F. Whyte, G.B. Rhind, M.A.A. Airlie, J.R. Catterall, C.M. Shapiro, et al.
The sleep hypopnea syndrome.
Am Rev Respir Dis, 137 (1988), pp. 895-898
[11.]
Rechtschaffen A, Rales A. A manual of standardized terminology. techniques and scoring system for sleep stages of human subjects. Bethesda: U.S. Government Printing Office, 1968 (NIH publication n.º 204).
[12.]
N.J. Douglas, S. Thomas, M.H. Jan.
Clinical value of polisomnography.
Lancet, 339 (1992), pp. 347-350
[13.]
J.M. Montserrat, J. Amibilia, J. Barbe, F. Capote, J. Duran, N.G. Mangado, et al.
Tratamiento del síndrome de apneas-hipopneas durante el sueño.
Arch Bronconeumol, 34 (1998), pp. 204-206
[14.]
V. Hoffstein, S. Mateika.
Predicting nasal continuous positive airway pressure.
Am J Respir Crit Care Med, 150 (1994), pp. 486-488
[15.]
J.M. Arriero, E. Chiner, J. Marco, Gómez-Espárrago, J. Corral.
Comparison of measured and predicted continuous positive airway pressure (CPAP) level in sleep apnea syndrome.
Eur Respir J, 10 (1997), pp. 188
[16.]
M.R. Pressman, J.M. Fry.
Relationship of autonomic nervous system activity to daytime sleepiness and prior sleep.
Sleep, 12 (1989), pp. 239-245
[17.]
R. Broughton, M. Aguirre, W. Dunham.
A comparison of multiple and single sleep latency and cerebral evoked potential (P300) measures in the assessment of excessive daytime sleepiness in narcolepsy-cataplexy.
Sleep, 11 (1988), pp. 537-545
[18.]
E. Hoddes, V. Zarcone, H. Smythe, R. Phillips, W.C. Dement.
Quantification of sleepiness: a new approach.
Psychophysiology, 10 (1973), pp. 431-436
[19.]
M. Flerbert, M.W. Johns, C. Dore.
Factor analysis of analogue scales measuring subjective feelings before and after sleep.
Br J Med Psychol, 49 (1976), pp. 373-379
[20.]
T.E. Weaver, A.M. Laizner, L.K. Evans, G. Maislin, D.K. Chugh, K. Lyon, et al.
An instrument to measure functional status outcomes for disorders of excessive sleepiness.
Sleep, 20 (1997), pp. 835-843
[21.]
C. Guilleminault, R. Stoohs, A. Clerk, M. Cetel, P. Maistros.
A cause of excessive daytime sleepiness.
The upper airway resistance syndrome. Chest, 104 (1993), pp. 781-787
[22.]
I. Izquierdo-Vicario, M.J. Ramos-Platón, D. Conesa-Peraleja, A.B. Lozano-Parra, J. Espinar-Sierra.
Epworth Sleepiness Scale in a sample of the Spanish population.
Sleep, 20 (1997), pp. 676-677
[23.]
M.W. Johns.
Sleepiness in different situations measured by the Epworth Sleepiness Scale.
Sleep, 17 (1994), pp. 703-710
Copyright © 1999. Sociedad Española de Neumología y Cirugía Torácica
Archivos de Bronconeumología
Article options
Tools

Are you a health professional able to prescribe or dispense drugs?